Cover Image
市場調查報告書

印度的醫療服務業:2015∼2020年

Medical Services Industry in India 2015-2020

出版商 NOVONOUS 商品編碼 338542
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的醫療服務業:2015∼2020年 Medical Services Industry in India 2015-2020
出版日期: 2015年08月24日 內容資訊: 英文 51 Pages
簡介

印度的醫療服務業,預計到2020年以年複合成長率16%擴大,達到10億400萬美元。印度的遠端照護產業受民間部門大幅貢獻,預計今後也以年複合成長率12.35%擴大至2020年成為2,437萬美元。

本報告提供印度的醫療服務市場相關的詳細調查、至2020年的成長預測、市場上競爭趨勢、SWOT分析、未來趨勢與機會、策略性建議等彙整資料。

第1章 摘要整理

第2章 簡介

  • 印度的醫療服務業
    • 遠端照護
    • 遠隔放射線
    • 居家醫療服務
    • 醫學記錄轉印
    • 臨床實驗及藥物檢驗

第3章 印度的醫療服務業的需求

  • 都市化趨勢和國民收入的增加
  • 印度的人口
  • 景氣變動

第4章 印度的醫療服務業預測

  • 印度的醫學記錄轉印產業預測:2015∼2020年
  • 印度的民間部門的遠端照護產業預測:2015∼2020年

第5章 印度的醫療服務業的成長促進因素與阻礙因素

第6章 印度的醫療服務業相關政策

第7章 印度的醫療服務業相關風險

  • 信用風險
  • 政策風險
  • 技術性風險

第8章 印度的醫療服務業相關產業團體

第9章 印度的醫療服務業分析模式

第10章 策略性建議

  • 對醫療服務供應商
  • 對政策決策者

圖表

目錄
Product Code: NOV0815004

Medical Services Industry which predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others is expected to create huge opportunities in Indian market by 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% and reach US$ 1.004 billion by 2020, finds a new research report launched by NOVONOUS.

In the sphere of Telemedicine in India, Private players contribute to the chunk of the market size. Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% and reach US$ 24.37 million by 2020.

Spanning over 51 pages and 30 exhibits, “Medical Services Industry in India 2015-2020” report presents an in-depth assessment of the medical services industry from 2015 till 2020.

Scope of the Report:

  • This report provides a detailed view of Indian medical services market.
  • This report identifies the need for focusing on medical services sector in India.
  • This report provides detailed information on growth forecasts for medical transcription industry in India up to 2020.
  • This report provides detailed information on growth forecasts for private sector telemedicine industry in India up to 2020.
  • The report identifies the growth drivers and inhibitors for medical services industry in India.
  • This study also identifies policies related to pharmaceuticals market in India.
  • The report identifies various credit, policy and technical risks associated with medical services industry in India.
  • This report identifies key industry bodies and associations and their role in Indian medical services market.
  • This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian medical services market.
  • This report provides Porter's Five Forces analysis for medical services industry in India.
  • This report provides SWOT (strengths, weakness, opportunities and threats) analysis for medical services industry in India.
  • This report also provides strategic recommendations for policy makers and medical services providers.

Table of Contents

1. Executive Summary

  • Scope of the Medical Services Industry in India 2015 - 2020 Report
  • Research Methodology

2. Introduction - Pharma Industry in India

  • 2.1. Medical Services Industry in India
    • 2.1.1. Telemedicine
      • 2.1.1.1. Telemedicine Industry Value Chain
    • 2.1.2. Teleradiology
      • 2.1.2.1. Teleradiology Industry Value Chain
    • 2.1.3. Homecare Healthcare Services
      • 2.1.3.1. Homecare Services Industry Value Chain
    • 2.1.4. Medical Transcription
      • 2.1.4.1. Medical Transcription Industry Value Chain
    • 2.1.5. Clinical Trial and Drug Testing
      • 2.1.5.1. Clinical Trial and Drug Testing Industry Value Chain

3. Need for Medical Services Industry in India

  • 3.1. Urbanization Trends and Rising National Income
  • 3.2. Large Population of India
  • 3.3. Economic viability

4. Forecast for Medical Services Industry in India

  • 4.1. Forecasts for Indian Medical Transcription Industry 2015-2020
  • 4.2. Forecasts for Indian Private Sector Telemedicine Industry 2015-2020

5. Growth Drivers and Inhibitors for Medical Services Industry in India

  • 5.1. Growth Drivers for Medical Services Industry in India
  • 5.2. Growth Inhibitors for Medical Services Industry in India

6. Policies Related to Pharmaceuticals Industry in India

  • 6.1. Central Government Policies
    • 6.1.1. Essential Commodities Act 1955
    • 6.1.2. Drugs and Cosmetics Act 1940(As amended in June 2005)
    • 6.1.3. National Pharmaceutical Pricing Policy 2012
    • 6.1.4. Drug Price Control Orders (DPCO)
    • 6.1.5. Drug Policy 1986
    • 6.1.6. Pharmaceutical Policy - 2002
  • 6.2. Guidelines related to Clinical Trial in India
  • 6.3. Guidelines related to Marketing in Indian Pharmaceuticals Industry

7. Risks Associated with Medical Services Industry in India

  • 7.1. Credit Risk
    • 7.1.1. Credit Risks Associated with Indian Medical Services Industry
  • 7.2. Policy Risk
    • 7.2.1. Policy Risks Associated with Indian Medical Services Industry
  • 7.3. Technical Risk
    • 7.3.1. Technical Risks Associated with Indian Medical Services Industry

8. Industry Associations Related to Indian Pharmaceuticals Industry

  • 8.1. Indian Drug Manufacturers' Association (IDMA)
  • 8.2. Indian Pharma Machinery Manufacturers Association (IPMMA)
  • 8.3. Indian Pharmaceutical Association (IPA)
  • 8.4. Organisation of Pharmaceutical Producers of India (OPPI)
  • 8.5. Association of Indian Medical Device Industry (AIMED)

9. Analysis Models for Indian Medical Services Industry

  • 9.1. PESTEL Analysis of Medical Services Industry in India
  • 9.2. SWOT Analysis of Indian Medical Services Industry
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 9.3. Porter's Five Forces Analysis of Indian Medical Services Industry

10. Strategic Recommendations

  • 10.1. Recommendations for Medical Service Providers
  • 10.2. Recommendations for Policy Makers
  • List of Exhibits
  • Notes
  • Company Information

List of Exhibits

  • Exhibit 2.1: Healthcare spending as % of GDP in populous countries - 2012
  • Exhibit 2.2: Telemedicine Industry Value chain
  • Exhibit 2.3: Teleradiology Industry Value chain
  • Exhibit 2.4: Homecare Services Industry Value Chain
  • Exhibit 2.5: Medical Transcription Industry Value Chain
  • Exhibit 2.6: Value Chain for Clinical trials in India
  • Exhibit 3.1: Urban Population in India (2000-2020)
  • Exhibit 3.2: Net National per Capita Income of India 2011-2015
  • Exhibit 3.3: Top Indian States with highest Urban & Rural IMR per 1000 birth - 2013
  • Exhibit 3.4: Top Ten disease causing death in India (2013-14)
  • Exhibit 4.1: Estimated Market size of the Global Medical Transcription Industry 2015-2020
  • Exhibit 4.2: Estimated Market size of The Indian Medical Transcription Industry 2015-2020 in USD million
  • Exhibit 4.3: Estimated CAGR% of the Indian Medical Transcription Industry 2015-2020
  • Exhibit 4.4: Indian Private Sector Telemedicine Market 2011-2014 (in USD million)
  • Exhibit 4.5: Estimated Market size of Indian Private Sector Telemedicine Industry 2015-2020 in USD million
  • Exhibit 4.6: Estimated CAGR% of Indian Private Sector Telemedicine Industry 2015-2020
  • Exhibit 5.1: Growth Drivers and Inhibitors for Medical Services Industry in India
  • Exhibit 6.1: Code for Marketing practices in Indian Pharmaceuticals Industry
  • Exhibit 8.1.1: Key Information of IDMA
  • Exhibit 8.1.2: Contact details of IDMA
  • Exhibit 8.2.1: Key information of IPMMA
  • Exhibit 8.2.2: Contact details of IPMMA
  • Exhibit 8.3.1: Key Information of IPA
  • Exhibit 8.3.2: Contact details of IPA
  • Exhibit 8.4.1: Key information of OPPI
  • Exhibit 8.4.2: Contact details of OPPI
  • Exhibit 8.5.1: Contact information for AIMED
  • Exhibit 9.1: PESTEL Analysis of the Indian Medical Services Industry
  • Exhibit 9.2: SWOT Analysis of Indian Medical Services Industry
  • Exhibit 9.3: Porter's Five Forces Analysis of Indian Medical Services Industry
Back to Top